Comparison of the cellular molecular stress responses after treatments used in bladder cancer.
OBJECTIVE
To investigate the molecular stress responses related to the quality of recovery of normal tissue after various treatments for bladder cancer, i.e. hyperthermia, ionizing radiation, mitomycin-C and 5-aminolaevulinic acid photodynamic therapy (ALA-PDT).


METHODS
The study focused particularly on intracellular fibroblast levels of heat-shock protein-47 (HSP47) and HSP72, which are associated with collagen metabolism and the development of tolerance to repeated treatment, respectively. Iso-effective treatment doses (50% clonogenic cell survival) of each method were delivered to a 3T6 murine fibroblast model. Intracellular extracts were analysed at 3, 6, 9, 12 and 24 h after treatment, using Western blot analysis to compare the levels of HSP47 and HSP72. Time-matched treatment and control groups were quantified by comparison with actin and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression using appropriate software.


RESULTS
There were various changes in levels of HSP expression with treatment method; HSP47 levels were significantly higher after hyperthermia and radiation but not with mitomycin-C or ALA-PDT. HSP72 levels were significantly higher with all methods except ALA-PDT.


CONCLUSIONS
Hyperthermia and ionizing radiation are associated with early increases in levels of HSP47 (a marker of collagen metabolism), in contrast to ALA-PDT and mitomycin-C. These findings are compatible with clinical findings where fibrosis/scarring is common with the first two but not the last two methods. In addition, all methods except ALA-PDT are associated with an increase in HSP 72 (a protein associated with cellular tolerance) and this may help to explain, at a cellular level, why resistance to repeated ALA-PDT treatments does not seem to occur.
Shackley
D C
DC
CRC Experimental Radiation Oncology Group, Paterson Institute for Cancer Research, Manchester, UK. Daveshackley@hotmail.com
Haylett
A
A
Whitehurst
C
C
Betts
C D
CD
O'Flynn
K
K
Clarke
N W
NW
Moore
J V
JV
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D015153:Blotting, Western; D003094:Collagen / Q000378:metabolism*; D050958:HSP47 Heat-Shock Proteins; D050884:HSP72 Heat-Shock Proteins; D006360:Heat-Shock Proteins / Q000378:metabolism*; D006979:Hyperthermia, Induced / Q000379:methods; D051379:Mice; D016685:Mitomycin / Q000627:therapeutic use; D010778:Photochemotherapy / Q000379:methods; D013312:Stress, Physiological / Q000209:etiology / Q000378:metabolism; D014407:Tumor Cells, Cultured; D001749:Urinary Bladder Neoplasms / Q000378:metabolism* / Q000628:therapy*
D000903:Antibiotics, Antineoplastic; D050958:HSP47 Heat-Shock Proteins; D050884:HSP72 Heat-Shock Proteins; D006360:Heat-Shock Proteins; C494661:Serpinh1 protein, mouse; D016685:Mitomycin; D003094:Collagen